Omneity® Pellets
All-In-One Vitamin & Mineral Pellet
Topic:Disease Treatment
Disease treatment in horses encompasses a range of medical interventions and management strategies aimed at addressing various health conditions affecting equine species. These treatments can include pharmacological approaches, such as the administration of antibiotics, anti-inflammatory drugs, and antiparasitic medications, as well as non-pharmacological methods like physical therapy, dietary adjustments, and surgical procedures. The selection of appropriate treatments depends on the specific disease, its severity, and the individual needs of the horse. This topic brings together peer-reviewed research studies and scholarly articles that explore the efficacy, safety, and advancements in therapeutic options for equine diseases, providing insights into best practices and emerging trends in equine veterinary medicine.
Ischaemic necrosis of the navicular bone and its treatment. In a survey of 95 control horses and 16 horses with navicular disease, the incidence of erosions and discoloration of the flexor cartilage of the navicular bone was no different between the control horses and those with navicular disease. All cases of navicular disease showed thrombosis of the distal navicular nutrient arteries and this could be related to a change to a rounded or flask shape of the distal nutrient foramen of the navicular bone. Erosions and discoloration of the navicular bone are therefore of no significance in navicular disease. Previously described lines of treatment are of...
Fetal tissue transplantation for immunotherapy of combined immunodeficiency in horses. Six young horses with combined immunodeficiency were given liver cells intravenously or intraperitoneally and thymuses subcutaneously from equine fetuses ranging from 68 to 110 days of gestational age. Three of four horses given cells from fetuses over 90 days of age developed lesions compatible with graft versus host reactions. One horse given cells from an 80-day fetus developed mitogen-responsive lymphocytes, synthesized immunoglobulins of the four major equine classes, and survived to 11.5 months of age. The sixth foal receiving cells from a 68-day fetus showed no discernable effects from ...
Immunotherapy in ocular equine sarcoid. A modified Bacillus Calmette-Guerin (BCG) preparation was used successfully in the treatment of 7 cases of equine sarcoid. The BCG preparation was injected into the lesions. The longest period of remission has been 24 months, and the shortest period of remission has been 9 months, with no signs of recurrence of the tumor in any of the presented cases.
Orgotein in equine navicular disease: a double blind study. Fourteen horses (7 treated with orgotein and 7 treated with a placebo) with navicular disease were studied on a double blind basis. All 14 horses had clinical and radiographic evidence of navicular disease. Orgotein and the placebo were administered by juxtabursal injection. Of the 7 orgotein-treated horses, 3 responded but none of the 7 placebo-treated horses responded. The difference was statistically significant (P less than 0.05).
Stability of the lyophilized F(ab’)2 fragments of horse tetanus antibodies isolated by affinity chromatography. F(ab')2 fragments of horse tetanus antibodies were obtained from horse hyperimmune sera after peptic digestion. The digest was passed through a column of tetanus toxoid coupled with Sepharose 4B, F(ab')2 fragments were eluted with a solution of 5 mM HCl in 150 mM NaCl and the eluates were concentrated by ultrafiltration and lyophilized. Glycine and human serum albumin were used as stabilizing agents. Polyacrylamide gel electrophoretic mobility and molecular weight of the fragments remained unchanged after lyophilization. Freeze-dried preparations stored two months at 56 degrees C showed only a...
The correction of uterine torsion in a mare by caesarean section. A 9-year-old mare exhibiting signs of colic late in pregnancy was presented. Uterine torsion was diagnosed and corrected by caesarean section. A live foal was delivered and the mare survived the surgical interference.
Atresia of the nasolacrimal orifice in two thoroughbreds. Two cases of bilateral atresia of the nasolacrimal orifice are described. The presenting sign was a persistent ocular discharge, clear in the one case and purulent in the other. Treatment by the creation of a fistula between the distal extremity of the blind ending duct and the nasal cavity was successful in both cases.
Prolonged interovulatory interval after oestradiol treatment in mares. This study was designed to test if oestradiol treatment would prevent or delay luteolysis in mares. Mares (5/group) received 0, 0.1, 1.0 or 10.0 mg oestradiol-17 beta daily from the day of ovulation until the next ovulation or for a maximum of 32 days. This treatment did not prevent luteolysis which occurred 15.8, 16.8, 15.8 and 17.3 days after the previous ovulation for the mares treated with 0, 0.1, 1.0 and 10.0 mg oestradiol respectively. Although oestradiol treatment failed to alter oestrous behaviour after luteolysis, daily treatment with 10.0 mg oestradiol prevented follicular growth and...
Contagious equine metritis in Australia. Contagious equine metritis (CEM) was first diagnosed in Australia in August 1977 and it has since been found on 6 farms in 3 states, having been isolated from about 24 mares and 2 stallions. Details are given of the epidemiology and control procedures used to combat CEM on one farm. Difficulty was experience in successfully treating one infected stallion; this was thought to be associated with inadequate cleaning and treating of the diverticulum of the urethral fossa. Introduction of the disease has had far-reaching consequences and may well result in the adoption of routine bacteriological te...
